Literature DB >> 15071746

Micronucleus formation in lymphocytes of children from the vicinity of Chernobyl after (131)I therapy.

W-U Müller1, S Dietl, K Wuttke, C Reiners, J Biko, E Demidchik, C Streffer.   

Abstract

After the Chernobyl accident a statistically significant increase in the number of children with thyroid tumours was observed. In this study 166 children with and 75 without thyroid tumours were analysed for micronucleus formation in peripheral blood lymphocytes using the cytochalasin B approach. The following factors did not significantly affect micronucleus formation: gender, age at the time of the first (131)I treatment, tumour stage, tumour type, or metastases; a statistically significant increase in the number of micronuclei, however, was observed for the residents of Gomel compared to other locations, such as Brest, Grodno, and Minsk. The children with tumours received (131)I treatment after surgical resection of the tumours. This gave us the opportunity to systematically follow the effect of (131)I on micronucleus formation. A marked increase was observed 5 days after the (131)I treatment followed by a decrease within a 4-7 months interval up to the next application, but the pre-treatment levels were not achieved. Up to 10 therapy cycles were followed each including an analysis of micronucleus formation before and 5 days after (131)I application. The response of the children was characterised by clear individual differences and the increase/decrease pattern of micronucleus frequencies induced by iodine-131 was correlated with a decrease/increase pattern in the number of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071746     DOI: 10.1007/s00411-004-0233-z

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  14 in total

1.  Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.

Authors:  S Gutiérrez; E Carbonell; P Galofré; A Creus; R Marcos
Journal:  Eur J Nucl Med       Date:  1999-12

2.  Micronucleus yield and colorimetric test as indicators of damage in patients' lymphocytes after 131I therapy.

Authors:  C Catena; D Conti; G Trenta; E Righi; F Breuer; F F Melacrinis; T Montesano; G Ventroni; G Ronga
Journal:  J Nucl Med       Date:  2000-09       Impact factor: 10.057

3.  Adaptive response in patients treated with 131I.

Authors:  M A Monsieurs; H M Thierens; A M Vral; C Van De Wiele; L I De Ridder; R A Dierckx
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

4.  Measurement of micronuclei in lymphocytes.

Authors:  M Fenech; A A Morley
Journal:  Mutat Res       Date:  1985 Feb-Apr       Impact factor: 2.433

5.  Micronuclei and 3AB-index in patients receiving iodine-131 therapy.

Authors:  C Catena; P Villani; R Nastasi; D Conti; E Righi; G Salerno; V A Righi; G Ronga
Journal:  J Nucl Biol Med       Date:  1994-12

6.  Estimation of risk based on biological dosimetry for patients treated with radioiodine.

Authors:  M A Monsieurs; H M Thierens; C V van de Wiele; A M Vral; I A Meirlaen; H A de Winter; C J de Sadeleer; L I de Ridder; J M Kaufman; R A Dierckx
Journal:  Nucl Med Commun       Date:  1999-10       Impact factor: 1.690

7.  Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.

Authors:  N Watanabe; K Yokoyama; S Kinuya; N Shuke; M Shimizu; R Futatsuya; T Michigishi; N Tonami; H Seto; D A Goodwin
Journal:  J Nucl Med       Date:  1998-03       Impact factor: 10.057

8.  Effect of in vivo exposure to iodine-131 on the frequency and persistence of micronuclei in human lymphocytes.

Authors:  G K Livingston; A E Foster; H R Elson
Journal:  J Toxicol Environ Health       Date:  1993 Oct-Nov

9.  A cytogenetic follow-up study of thyroid cancer patients treated with 131I.

Authors:  S Gutiérrez; E Carbonell; P Galofréa; N Xamena; A Creus; R Marcos
Journal:  Cancer Lett       Date:  1995-05-08       Impact factor: 8.679

10.  Micronuclei in human lymphocytes irradiated in vitro or in vivo.

Authors:  H W Gantenberg; K Wuttke; C Streffer; W U Müller
Journal:  Radiat Res       Date:  1991-12       Impact factor: 2.841

View more
  5 in total

Review 1.  Strong association between cancer and genomic instability.

Authors:  Christian Streffer
Journal:  Radiat Environ Biophys       Date:  2009-12-24       Impact factor: 1.925

Review 2.  Micronuclei in neonates and children: effects of environmental, genetic, demographic and disease variables.

Authors:  Nina Holland; Alexandra Fucic; Domenico Franco Merlo; Radim Sram; Micheline Kirsch-Volders
Journal:  Mutagenesis       Date:  2011-01       Impact factor: 3.000

3.  DNA damage in lymphocytes and buccal mucosa cells of children with malignant tumours undergoing chemotherapy.

Authors:  E M Minicucci; D A Ribeiro; B de Camargo; M C Costa; L R Ribeiro; D M Favero Salvadori
Journal:  Clin Exp Med       Date:  2008-07-11       Impact factor: 3.984

4.  No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis.

Authors:  Giovanni Federico; Giuseppe Boni; Barbara Fabiani; Lisa Fiore; Patrizia Lazzeri; Francesco Massart; Claudio Traino; Carmela Verola; Giuseppe Saggese; Giuliano Mariani; Roberto Scarpato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-22       Impact factor: 9.236

Review 5.  Factors Affecting the Nuclei in Newborn and Children.

Authors:  Christos Arnaoutoglou; Anastasia Keivanidou; Georgios Dragoutsos; Ioannis Tentas; Soultana Meditskou; Paul Zarogoulidis; Dimitrios Matthaios; Chrysanthi Sardeli; Aris Ioannidis; Eleni Isidora Perdikouri; Andreas Giannopoulos
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.